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1056Objectives: Patients with bicuspid aortic valves (BAV) are predisposed to developing ascending thoracic aortic
aneurysms (TAA) at an earlier age than patients who develop degenerative TAAs and have a tricuspid aortic
valve (TAV). The hypothesis tested is that BAV-associated aortopathy is mediated by a mechanism of matrix
remodeling that is distinct from that seen in TAAs of patients with tricuspid aortic valves.
Methods: Aortic specimens were collected during ascending aortic replacement, aortic valve replacement, and
heart transplants from nonaneurysmal (NA) donors and recipients. Matrix architecture of the aortic media was
assessed qualitatively using multiphoton microscopy followed by quantification of collagen and elastin fiber
orientation. a-Elastin was determined and matrix maturity was assessed by quantifying immature and mature
collagen and lysyl oxidase (Lox) expression and activity in aortic specimens. Matrix metalloproteinase-2/9
activity was quantified in aortic smooth muscle cells.
Results: Elastin and collagen fibers were more highly aligned in BAV-NA and BAV-TAA cases than in
TAV-TAA cases, whereas TAV-TAA cases were more disorganized than TAV-NA cases. a-Elastin content
was unchanged. Immature collagen was reduced in BAV-NA and BAV-TAA cases when compared with
TAV-NA and TAV-TAA cases. Mature collagen was elevated in TAV-TAA cases compared with TAV-NA and
BAV-TAA cases. There was a trend toward elevated Lox gene expression and activity and matrix
metalloproteinase-2/9 activity for TAV-TAA, BAV-NA, and BAV-TAA specimens.
Conclusions: The highly aligned matrix architecture in patients with BAVs indicates that wall remodeling is
distinct from TAV-TAA. Altered matrix architecture and reduced collagen maturity suggest that the effector
molecules mediating the remodeling of TAAs are different in BAV and TAV cases. (J Thorac Cardiovasc
Surg 2014;147:1056-64)Congenital bicuspid aortic valve (BAV) is associated with
an aortopathy manifesting as ascending thoracic aortic
aneurysm (TAA) or aortic dissection. BAV is the most com-
mon congenital heart anomaly and affects 1% to 2% of the
population.1,2 Data from large surgical centers, including
our own, report a BAV occurrence rate of approximately
40% for patients undergoing aortic replacement as the
result of TAA. BAV is heritable,1,3 but the cause is
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The Journal of Thoracic and Cardiovascular Surassociated with BAV also is not defined, but the pathology
is localized distinctly to the ascending thoracic aorta.
A final common pathway ofmatrix degeneration is shared
between aneurysms of the ascending thoracic and abdomi-
nal aorta. Increased expression of the degrading matrix
metalloproteinases (MMPs) and reduced expression of their
counterparts, the tissue inhibitors of matrix metalloprotei-
nases (TIMPs), result in fragmentation of collagen and elas-
tin fibers. Histopathologic observations of cystic medial
degeneration (CMD), smooth muscle cell (SMC) loss,
lack of inflammatory cells, and proteoglycan accumulation
are unique to TAAs and suggest that the inciting mechanism
of MMP/TIMP imbalance and matrix degeneration differs
for ascending thoracic and abdominal aortic aneurysms.
Patients with BAVare at an increased risk of developing
TAA at least 10 to 15 years earlier than patients with TAV.
Although the mechanism of action mediating matrix degen-
eration in BAV-associated aortopathy is unknown, we postu-
late that SMCs of the BAVaorta possess an inherent defect
that causes a material property change in the vessel wall
leading to TAA formation. We previously demonstrated
that the oxidative stress response is compromised in SMCs
in patients with BAV.4 We recently reported altered biome-
chanical strength of the vessel wall between BAVand TAVgery c March 2014
Abbreviations and Acronyms
BAV ¼ bicuspid aortic valve
CMD ¼ cystic medial degeneration
HYP ¼ hydroxyproline
MMP ¼ matrix metalloproteinase
MPM ¼ multiphoton microscopy
NA ¼ nonaneurysmal
NOI ¼ normalized orientation index
OI ¼ orientation indice
SMC ¼ smooth muscle cell
TAA ¼ thoracic aortic aneurysm
TAV ¼ tricuspid aortic valve
TGF ¼ transforming growth factor
TIMP ¼ tissue inhibitors of matrix
metalloproteinase
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hypothesize that TAAs arise in patients with BAVand TAV
by unique mechanisms of matrix remodeling. To test this
hypothesis, collagen and elastin matrix architecture and
maturity were qualitatively and quantitatively studied in
human thoracic aorta from patients with and without
aortic aneurysm. We found that patients with BAV and
patients with TAV exhibit distinctly different aortic matrix
architecture, suggesting distinct mechanisms of aortic wall
remodeling in the 2 populations.E
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Patient Selection and Specimen Acquisition
Ascending thoracic aortic specimens were collected during elective
surgery for ascending aortic replacement or aortic valve replacement from
patients with BAVor tricuspid aortic valve (TAV) with institutional review
board approval and informedpatient consent. Specimenswere also collected
from heart transplant donors and recipients with TAVand absence of aortic
disease with approval from the Center for Organ Recovery and Education or
institutional review board approval and informed patient consent,
respectively. Patient demographics of sex, age, maximal orthogonal aortic
diameter, degree of aortic insufficiency and stenosis, and history of
hypertension and cigarette smoking were documented (Table 1). Patients
with TAA enrolled in our tissue bank with BAV (median age, 53 years;
n ¼ 142) presenting for elective surgery at the University of Pittsburgh
Medical Center for ascending aortic replacement do so at least 10 years
earlier than patients with TAV (median age 63 years; n ¼ 99). Specimens
chosen for each experiment were diameter-matched (median diameters
within 2 mm) for patients with TAV-TAA and patients with BAV-TAA,
and ages span the distribution given above. Specimens of both sexes were
included in the study.
On excision, the specimens were placed in ice-cold saline and
transported to the laboratory. A portion of tissuewas processed for isolation
of primary aortic SMC cultures as previously described.4,6
Multiphoton Microscopy of Aortic Matrix
Architecture
A 1 cm2 portion of the specimen was dissected, noting proximal/distal
orientation. The adventitia was left intact to avoid potential deformation inThe Journal of Thoracic and Carthe native matrix architecture. The specimen was kept in phosphate-
buffered saline on ice and imaged immediately (within 2 hours of harvest)
using multiphoton microscopy (MPM) or fixed in 2% paraformaldehyde
for 1 hour, followed by storage in phosphate-buffered saline at 4C until
MPM was performed. Specimens were imaged using an Olympus
FV1000 MPE (Tokyo, Japan) equipped with a Spectra-Physics DeepSee
Mai Tai Ti-Sapphire laser (Newport, Mountain View, Calif) using an
excitation wavelength of 830 nm and 1.12 numerical aperture 253 MPE
water immersion objective. Epi-detectors were used to collect the second
harmonic generation at 400  50 nm for collagen fibers and autofluores-
cence of elastin at 525  25 nm. Images were captured using a dwell
time of 4 ms/pixel and a Kalman filter of 2. Images of the media were
captured as 2-mm slices starting just beyond the intimal surface
sequentially moving toward the adventitia. An attempt to capture images
spanning the full thickness of the medial layer was made with each
specimen; however, the number of images collected varied with each
sample because of thickness and geometry of the specimen and ranged
from 14 to 108 mm.
Determination of Collagen and Elastin Fiber
Alignment
After MPM analysis, projected image stacks were assembled for each
channel (collagen and elastin separately) using ImageJ (National Institutes
of Health, Bethesda, Md). To quantify collagen and elastin fiber orientation
on superimposed 2-dimensional image stacks, the gradient of image
intensity at each pixel taken above a threshold was determined for an edge
detection algorithm using a custom MATLAB program (The MathWorks
Inc, Natick,Mass) previously described.7 Briefly, these values were entered
into an accumulator bin defined over a subregion, and for each angle the
summed gradient-weighted contribution of each pixel was calculated.
Histograms of dominant orientation, defined as the angle associated with
the maximum accumulator bin value were plotted, and orientation indices
(OIs) were determined on the basis of variance of fiber angle (Dq) of 50%
of the total number of fibers as one half the area under the curve of fiber
angle distribution histogram. For images with a high degree of fiber
alignment, it was necessary to rotate the image clockwise 90 degrees to
generate half-area calculations from fiber-count angle histograms. The
normalized orientation index (NOI) was then calculated from Equation 1
as described previously8 where OI ¼ Dq.
NOI ¼ 90-OI=903100 so that NOI V ½0; 100 (Equation 1)
RNA Isolation and Quantitative Real-Time
Polymerase Chain Reaction
A portion of each specimenwas placed in RNAlater (Life Technologies,
Carlsbad, Calif) and stored at 20C until use. Total RNA was isolated
using the RNeasy Plus kit (Qiagen, Valencia, Calif). Gene expression of
Lysyl oxidase (Lox) was quantified by real-time polymerase chain reaction
as previously described6 using the One-Step Taqman PCR kit and
custom-designed Taqman gene expression assay for human Lox (Assay
ID# Hs00184700_m1) (Life Technologies).
Histology
Specimens (0.5 3 1 cm2) were fixed in 10% buffered formalin and
paraffin embedded. Four-micron sections were stained using Masson’s
trichrome and Verhoeff–Van Gieson (Research Histology Services,
University of Pittsburgh Thomas E. Starzl Transplantation Institute,
Pittsburgh, Pa) to ascertain collagen and elastin composition respectively.
Slides were stained using picrosirius red stain kit (Polysciences Inc,
Warrington, Pa) according to the manufacturer’s instructions to assess
collagen fiber thickness. Slides were visualized using a Nikon
TE-2000-E inverted microscope under polarized light and captured usingdiovascular Surgery c Volume 147, Number 3 1057
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(Nikon Corporation, Melville, NY). Mean area fractions of red/orange
and green fibers were quantified.
Determination of Soluble and Insoluble Collagen
Snap-frozen aortic specimens were pulverized under liquid nitrogen and
weighed. Pepsin-soluble collagen was extracted using 5 mg/mL pepsin in
0.5 mol/L glacial acetic acid (20 mL/g tissue) overnight at 4C. Samples
were centrifuged at 2100g for 6 minutes at room temperature. Undenatured
soluble ‘‘immature’’ collagen was detected from the supernatant fraction
using the Sircol assay according to the manufacturer’s instructions and
a standard curve of type I collagen (Accurate Chemical and Scientific
Corporation, Westbury, NY) and normalized to tissue mass.
Insoluble collagen content was estimated from the pellet fraction after
pepsin digestion using a colorimetric hydroxyproline (HYP) assay.9
Pelleted samples with a minimal volume (<10 mL) of pepsin solution
were lyophilized, massed, and flame-sealed in 10-mm Pyrex tubes with
100 mL of 6N HCl containing 0.5% (v/v) phenol. Samples were
incubated at 110C for 24 hours and dried under vacuum. Samples were
resuspended in 1% (v/v) HCl, incubated at 50C, and an equivalent
amount of NaOH. Detection of HYP was achieved by addition of
0.056 mol/L Chloramine T for 25 minutes at room temperature.
Freshly prepared 1 mol/L Ehrlich’s reagent was added, followed by
incubation at 65C for 20 minutes. HYP content was estimated from
a standard curve of freshly prepared HYP (Sigma, St Louis, Mo).
Absorbance was measured at 550 nm in a spectrophotometer (SpectraMax
M2, Model #D02667; Molecular Devices, LLC, Sunnyvale, Calif) in
duplicate wells. HYP values were normalized to the starting mass of the
insoluble pellet.
Determination of Elastin Content
Insoluble a-elastin content was determined from aortic specimens using
the Fastin Elastin assay (Accurate Chemical and Scientific Corporation)
according to the manufacturer’s instructions. Tissue samples were
pulverized under liquid nitrogen and weighed. Samples were incubated
in 750 mL of 0.25 mol/L oxalic acid in a 100C heating block for 1 hour.
Samples were brought to room temperature and centrifuged at 9300g for
10 minutes. The supernatant was digested a second time. Alpha-elastin
content was estimated from pooled supernatants using a standard curve
of a-elastin and normalized to weight of the tissue.
Determination of Lox and Matrix
Metalloproteinase-2/9 Activity
For quantification of Lox and MMP 2/9 activity, primary SMCs
(passage 4-5) were plated (5000 cells/cm2) in SMC growth medium
(Cell Applications, San Diego, Calif). Media were replenished every other
day, and conditioned medium was collected after 7 days. Samples were
assayed using the Amplite Fluorometric Lysyl Oxidase Assay Kit
(AAT Bioquest, Sunnyvale, Calif) or the Innozyme Gelatinase
(MMP-2/9) Activity Assay Kit (EMD Millipore, Billerica, Mass)
according to the manufacturers’ instructions and reported as fluorescence
units normalized to total protein of the conditioned media.TABLE 1. Study participant demographics
All samples N (M/F) Age, y (median ± SD) Aortic diameter, m
TAV-NA 23 (17/6) 54.0  14.9 Nor
TAV-TAA 26 (22/4) 58.5  11.6 52.0
BAV-NA 15 (11/4) 56.0  14.4 <
BAV-TAA 39 (35/4) 54.0  9.7 50.0
SD, Standard deviation; HTN, hypertension; AI, aortic insufficiency; AS, aortic stenosis; T
BAV, bicuspid aortic valve.
1058 The Journal of Thoracic and Cardiovascular SurStatistical Analyses
Data reported represent mean  standard error of the mean of all
experiments performed. A 1-way analysis of variance was performed
followed by Fisher’s least significant difference post hoc test to determine
differences among patient groups using SPSS 19.0 software (SYSTAT
Software, Inc, Chicago, Ill). A Student t test was used to determine
diameter matching for TAV-TAA and BAV-TAAwithin experiments.RESULTS
MPM of the ascending thoracic aorta revealed matrix
architecture that was unique for patients with BAV
and TAV (Figure 1, left). Collagen and elastin fiber
architecture appeared to be organized randomly in patients
with TAV-TAA versus highly aligned for patients with
BAV-nonaneurysmal (NA) and BAV-TAA when compared
with TAV-NA. These observations are reflected in the fiber
angle count histograms as relatively sharp peaks
(parallel, high alignment) for TAV-NA, BAV-NA, and
BAV-TAA, or shallow peaks (random, low alignment) for
TAV-TAA, and are displayed in Figure 1 (right) for collagen
and elastin fibers. Quantification of matrix architecture as
a measure of NOI (Figure 2, A-D) revealed less elastin fiber
alignment for TAV-TAA than for TAV-NA (P ¼ .053)
(Figure 2, E). A similar trend was observed for collagen
(P ¼ .115) (Figure 2, F).
The matrix architecture of the BAVaorta was striking. In
contrast to patients with TAV-TAA, patients with BAV-TAA
exhibited a highly oriented fiber architecture that was
reminiscent of the architecture observed for a normal aorta
with respect to distribution of fiber angle alignment
(Figure 1). Elastin fiber alignment in BAV-TAA was
increased not only in patients with TAV-TAA but also in
patients with TAV-NA (P<.001) (Figure 2, E). A similar
relationship was determined for the elastin NOI of patients
with BAV-NAwhen compared with TAV-NA (P¼ .012) and
TAV-TAA (P < .001). Collagen NOI was increased in
BAV-NA (P ¼ .009) and BAV-TAA (P ¼ .037) when
compared with TAV-TAA (Figure 2, F). Predominant valve
pathology (aortic stenosis or aortic insufficiency) or BAV
cusp fusion morphology (right-left, right-noncoronary, or
true bicuspid) did not affect collagen or elastin NOIs
for BAV-TAA (data not shown). Collagen NOI was reduced
with increasing aortic diameter for patients with BAV-TAA
(R2 ¼ 0.73) but not for patients with TAV-TAA
(R2 ¼ 0.007). There was no correlation between elastinm (median ± SD) HTN% (#/N) History of smoking% (#/N)
mal 39.1% (9/23) 39.1% (9/23)
 7.1 65.4% (17/26) 23.1% (6/26)
40 60.0% (9/15) 26.7% (4/15)
 5.2 41.0% (16/39) 59.0% (23/39)
AV, tricuspid aortic valve; NA, nonaneurysmal; TAA, thoracic aortic aneurysm;
gery c March 2014
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(R2 ¼ 0.26) and BAV-TAA (R2 ¼ 0.002). Our findings of
distinct patterns of collagen and elastin matrix architecture
in the aortas of those with BAVand TAV led us to question
whether differences in matrix protein maturity exist in BAV
and TAV aortas.
Histologic analyses of aortic specimens confirmed CMD,
elastin fragmentation, and collagen disorganization in TAA
specimens irrespective of aortic valve morphology
(Figure 3, A). Nonuniform collagen distribution, elastin
fragmentation, and CMD were observed for TAV-TAA,
BAV-NA, and BAV-TAA.
There was no difference in a-elastin content among the
patient groups (P> .2) (Figure 3, B). To assess collagen
maturity, soluble collagen ‘‘newly synthesized, immature’’
and insoluble ‘‘cross-linked, mature’’ collagen was quanti-
fied. Immature collagen was reduced in BAV-NA and
BAV-TAA specimens when compared with TAV-NA and
TAV-TAA specimens (Figure 3, C) (P<.02) and unchanged
between TAV-NA and TAV-TAA specimens (P ¼ .826).
There was an elevated amount of mature collagen in
TAV-TAA relative to TAV-NA and BAV-TAA (P< .03)
(Figure 3, D). Mature collagen appeared to be increased
in BAV-NA relative to normal (P ¼ .105). Qualitative
(Figure 4, A) and quantitative (Figure 4, B) image analysis
of picrosirius red stained sections for each color represent-
ing thick (red) and thin (green) fibers suggested therewas an
increased amount of thicker diameter collagen for
TAV-TAA when compared with TAV-NA and BAV-TAA,
similar to that of insoluble, mature collagen (Figure 3, D).
To estimate cross-linking capability, Lox gene expression
was quantified and revealed a trend of elevated mRNA in
TAV-TAA, BAV-NA, and BAV-TAA cases (P ¼ .079)
(Figure 5, A), but there was an equivalent level of Lox
enzyme activity among all groups (P ¼ .999) (Figure 5,
B). MMP-2/9 activity appeared to be elevated in
TAV-TAA, BAV-NA, and BAV-TAA SMCs when compared
with TAV-NA (P¼ .189) (Figure 5,C). Gelatin zymography
for activeMMP-2 yielded a similar pattern (data not shown).
DISCUSSION
The hallmarks of TAAs in BAV and TAV cases are
CMD, elastin fragmentation, and SMC loss. However,
TAAs of patients with BAV and TAV are histologicallyAI% (#/N)
1þ 2-3þ 4þ
0% (0/23) 4.5% (1/23) 0% (0/23)
26.9% (7/26) 23.1% (6/26) 15.4% (4/26)
13.3% (2/15) 6.7% (1/15) 33.3% (5/15)
15.4% (6/39) 23.1% (9/39) 15.4% (6/39)
TABLE 1. Continued
The Journal of Thoracic and Carindistinguishable from one another and exhibit patient-to-
patient variability in matrix organization. Consequently,
characterization of valve-specific pathology is difficult.
There are disparate reports in the literature on collagen
content in various aortopathies. Some reported increased
collagen content in thoracic aortic dissections10,11 and
abdominal aortic aneurysms,12,13 whereas others reported
no change in collagen for Marfan-related TAA and
abdominal aortic aneurysm14 or BAV-associated TAA.15
Spatially dependent reductions in collagen have been
described for patients with BAV-TAA.16 We previously
observed elevated type I collagen mRNA levels in
BAV-TAAversus normal patients6 and found total collagen
content to be unchanged in BAV-TAAwhen compared with
TAV-TAA (J Pichamuthu et al, unpublished data). In the
current study, we demonstrate similar elastin content among
all patient groups. Thus, there may be a consensus
that differences in BAV versus TAV-associated TAA cannot
be reconciled by biochemical changes in the amount of
collagen and elastin.
To identify differences in aorticmatrixmicro-architecture
between BAVand TAV, we focused our efforts on a qualita-
tive and quantitative interrogation of collagen and elastin
architecture. Other reports have examined aortic matrix
architecture in human and animal models using electron
microscopy,17,18 a time-consuming and destructive process
with opportunities for introduction of artifact and screening
error. MPM has the capability of visualizing collagen and
elastin distinctly in freshly isolated native tissue with
minimal, nondestructive processing. We used MPM to
interrogate aortic matrix architecture in human aortic
specimens from patients with NA and aneurysmal BAV
and TAV. The differences in collagen and elastin fiber archi-
tecture were striking. Patients with TAV-TAA demonstrated
a random, multidirectional organization of collagen and
elastin. In contrast, we discovered that patients with BAV
displayed a highly aligned unidirectional and parallel fiber
architecture. Our findings are consistent with others who
proposed that defects in collagen microarchitecture
underlie the pathology of thoracic aortic aneurysms related
to Marfan syndrome.14 Of note, the aorta of patients with
abdominal aortic aneurysms and Marfan syndrome was
also reported to be stiffer than normal,19,20 presumably
because of a greater proportion of aligned collagen fibrils.14AS% (#/N)
Mild Moderate Severe
0% (0/23) 0% (0/23) 0% (0/23)
7.7% (2/26) 0% (0/26) 3.8% (1/26)
0% (0/15) 6.7% (1/15) 53.3% (8/15)
5.1% (2/39) 10.3% (5/39) 28.2% (11/39)
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FIGURE 1. Matrix architecture of human ascending thoracic aorta. Representative images of collagen (green) and elastin (red) fiber orientation acquired
using MPM (left). Magnification is 253. Histograms of collagen and elastin fiber angle counts (right). BAV, Bicuspid aortic valve; TAA, thoracic aortic
aneurysm; NA, nonaneurysmal; TAV, tricuspid aortic valve.
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than a collagen deficit mediating aneurysm formation has
been proposed for Marfan-related TAA.14 The stark1060 The Journal of Thoracic and Cardiovascular Surdifferences in collagen and elastin fiber architecture in
BAV versus TAV indicate that BAV aortopathy involves
a remodeling process distinct from that which occurs ingery c March 2014
FIGURE 2. Determination of matrix fiber orientation. A, Representative monochromatic image of collagen fiber matrix of a BAV-TAA case using MPM.
Magnification is 253. B, Vector map (blue arrows) of fiber alignment for image in (A). C, Increased magnification of box indicated in (B) to illustrate
fiber alignment vectors. D, Representative histogram of collagen fiber angle counts for BAV-TAA generated from MPM image in (A) to calculate the
orientation index (Dq). E and F, NOIs for elastin and collagen, respectively. Bars represent mean  standard error of the mean (SEM), n ¼ 5 (TAV-NA),
8, 9 (TAV-TAA), 6 (BAV-NA), and 10 (BAV-TAA). *Significant from TAV-NA. **Significant from TAV-TAA, P<.05. NOI, Normalized orientation index;
NA, nonaneurysmal; TAA, thoracic aortic aneurysm; TAV, tricuspid aortic valve; BAV, bicuspid aortic valve.
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BAV-NA also exhibited the same highly aligned fiber
orientation as those with BAV-TAA suggests remodeling
to be an early event, even before aortic dilatation. These
patients with BAV-NA have clinical aortic valve disease
and various degrees of aortic stenosis and insufficiency
(Table 1). Matrix remodeling in patients with BAV to
a more highly aligned fiber architecture appears to be an
inherent, early response perhaps as an adaptation to the
molecular pathology or turbulent systolic flow jets through
the BAV.21 The highly oriented collagen fibers may
account for our observed differences in vessel strength
between TAV-TAA and BAV-TAA5 (also J Pichamuthu
et al, unpublished data) because aligned collagen fibersThe Journal of Thoracic and Cartend to be stiffer than randomly oriented fibers,22,23 and
patients with BAV exhibit increased stiffness of
the ascending aorta irrespective of dilatation.24,25
Realignment of collagen fibers has been shown to
be driven by cell orientation,26 supporting our seminal
hypothesis that remodeling during TAA in the patient
with BAV is cell-mediated.4 Furthermore, the recognition
of highly aligned elastin fibers is consistent with the known
reduced elasticity of BAV-aorta.25 The logarithm for
determination of collagen and elastin fiber orientation was
previously applied to studies of stress-mediated collagen
fiber recruitment in rabbit carotid arteries.8 Our results
follow a similar premise in that collagen fiber alignment
in patients with BAV may constitute a remodelingdiovascular Surgery c Volume 147, Number 3 1061
FIGURE 3. Assessment of matrix composition and maturity. A, Verhoeff–Van Gieson (top) and Masson’s trichrome (bottom) for representative ascending
thoracic aortic specimens. Images were oriented such that the adventitial side is located at the top and intimal side on the bottom. Images were captured at
203magnification. Scale bar¼ 50 mm. B, Elastin content, n¼ 10 (TAV-NA), 9 (TAV-TAA), 5 (BAV-NA), and 11 (BAV-TAA). C, Immature collagen n¼ 8
(TAV-NA), 9 (TAV-TAA), 4 (BAV-NA), and 9 (BAV-TAA). D, Mature collagen n ¼ 8 (TAV-NA), 7 (TAV-TAA), 3 (BAV-NA), and 8 (BAV-TAA), and
bars represent mean SEM. *Significant from TAV-NA. **Significant from TAV-TAA, P<.05. TAV, Tricuspid aortic valve; TAA, thoracic aortic aneurysm;
BAV, bicuspid aortic valve; NA, nonaneurysmal.
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that contributes to stress-mediated mechanical stiffening
of the vessel.27 Collagen fibers were less aligned with
increasing aortic diameter for BAV-TAA but not
TAV-TAA, suggesting a secondary remodeling mechanism
in patients with BAV during progressive dilatation that
could be due to local variations in wall stress28 and warrants
further study. Patients with BAV may have an inability to
continually compensate for ongoing degeneration with
increasing pressure on the vessel with dilatation. The
uniquely remodeled architecture and altered biomechanical
responses in those with BAV and TAV5 (also J Pichamuthu
et al, unpublished data) suggest that different effectors lead
to microstructural defects that govern the remodeling
process.
Our finding of reduced immature collagen in patients
with BAV to TAV irrespective of aortic diameter supports
altered collagen remodeling mechanisms at play in the
BAV-associated aortopathy. Less immature collagen is
consistent with the established pattern of increased
MMP activity in BAV-associated TAAs,15,29,30 confirmed
here in SMCs from patients with TAV-TAA, BAV-NA,
and BAV-TAA, because immature, non–cross-linked
collagen is more susceptible to proteolysis. An alternative
explanation is that reduced immature collagen in BAV
could be the result of decreased post-transcriptional
modifications or increased pre–pro-collagen protein
turnover because we previously observed elevated type I1062 The Journal of Thoracic and Cardiovascular Surcollagen mRNA expression in patients with BAV-TAA.6
Mature collagen was increased in patients with TAV-TAA
when compared with patients with TAV-NA and
BAV-TAA, suggesting a collagen remodeling response in
patients with TAV-TAA that is lacking in patients with
BAV. Normal levels of immature collagen in TAV-TAA
despite elevated MMP activity also points to an altered
collagen remodeling response in BAV versus TAV cases.
Assessment of collagen fiber diameter via picrosirius red
staining concurred with our biochemical analysis of
insoluble collagen but did not indicate collagen fiber
diameter to be a prominent microstructural alteration for
patients with BAV.
These differences in collagen maturity and archi-
tecture appear to be independent from cross-linking
because Lox gene expression seemed to be elevated
similarly in pathologic specimens. The elevated Lox
mRNA pattern was congruent to that of type I collagen,
further suggesting that the transcriptional machinery
responsible for collagen and Lox expression is oversti-
mulated by the same unknown mechanism. Our results
complement others who found that Lox and type I
collagen were elevated in patients with Marfan
syndrome14 and postulated the involvement of trans-
forming growth factor (TGF)-b in this connective
tissue disorder.31 TGF-b1 is known to regulate collagen
and Lox expression and govern post-transcriptional and
post-translational processing of Lox.32 However, thegery c March 2014
FIGURE 4. Picrosirius red staining for collagen fibers in ascending
aorta. A, Representative micrographs of aortic specimens imaged using
linear polarized light showing thinner (green) and thicker collagen
fibers (red). Images were oriented such that the adventitial side is located
at the top and the intimal side is located on the bottom. Scale bar ¼ 100
mm. B, Quantification of the area fraction of green (open bars) and
red (solid bars). Bars represent mean  SEM, n ¼ 3 (TAV-NA),
4 (TAV-TAA), and 5 (BAV-NA, BAV-TAA). NA, Nonaneurysmal;
TAA, thoracic aortic aneurysm; BAV, bicuspid aortic valve; TAV, tricuspid
aortic valve.
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investigated.
These data collectively lead us to propose that the BAV
aorta remodels by a unique mechanism distinct from that
giving rise to TAA in patients with TAV. These alterations
in matrix architecture in BAV aorta are evident before
dilatation and well before the typically recommended point
of surgical intervention, which is when the aortic diameter
reaches a maximal orthogonal measurement between
50 and 55 mm. It is reasonable to surmise that with an
increased understanding of the role that matrix fiber
alignment and architecture play in the biomechanical
stability of the vessel wall, improved risk assessments forThe Journal of Thoracic and Cardevelopment of TAA and life-threatening dissections can
be attained. Further study on the direct impact of the
distinct pattern of matrix remodeling in patients with
BAV described here on the underlying known differences
in biomechanical strength, the putative cell-mediated
mechanisms governing the remodeling process, and consi-
deration of the effects of disrupted hemodynamics specific
to the pattern of BAV cusp fusion will help glean new
insight toward identifying the relative risk for aortic
catastrophe in patients with BAV. Interrogation of fetal
and pediatric specimens could offer insight on the timing
of matrix remodeling and whether the process is
adaptive or the distinct differences in architecture are
congenital. Ongoing efforts in our laboratory are
targeted on characterization of the effector molecules gov-
erning the matrix remodeling process in BAV-associated
aortopathy.Study Limitations
Because of the relatively small portion of tissue that is
able to be excised from NA patients with BAV during
elective aortic valve replacement, the number of assays
that can be performed per patient was limited, which
resulted in lower sample sizes for this cohort. The
TAV-NA group had appreciably less instances of aortic
insufficiency and no instances of AS because the majority
of the patients in this cohort were normal ‘‘healthy’’ organ
donors, making inferences on the impact of aortic valve
pathology on study outcomes difficult.CONCLUSIONS
The highly aligned matrix architecture in BAV patients
indicates that wall remodeling is distinct from TAV-TAA.
Altered matrix architecture and reduced collagen maturity
suggests that the effector molecules mediating remodeling
of TAA are different in BAV and TAV patients. It is
reasonable to surmise that, with an increased understanding
of the role matrix fiber alignment and architecture plays in
the biomechanical stability of the vessel wall, improved risk
assessments for development of TAA and life-threatening
dissections can be attained.
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FIGURE 5. Lox and MMP analysis. A, Lox mRNA expression in aortic tissue specimens n ¼ 17 (TAV-NA), 8 (TAV-TAA), 8 (BAV-NA), and 15
(BAV-TAA). B, Lox n¼ 5 (TAV-NA), 4 (TAV-TAA), 3 (BAV-NA), and 15 (BAV-TAA). C, MMP-2/9 activity n¼ 4 (TAV-NA), 5 (TAV-TAA), 3 (BAV-NA),
and 6 (BAV-TAA). NA, Nonaneurysmal; TAA, thoracic aortic aneurysm; TAV, tricuspid aortic valve; BAV, bicuspid aortic valve; MMP, matrix metallo-
proteinase; NOI, normalized orientation index.
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